Whitehawk Therapeutics, Inc. (WHWK)
NASDAQ: WHWK · Real-Time Price · USD
1.830
-0.081 (-4.21%)
Mar 31, 2025, 3:24 PM EDT - Market open
Company Description
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments.
It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025.
Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Whitehawk Therapeutics, Inc.
| Country | United States |
| Founded | 2007 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 89 |
| CEO | David Lennon |
Contact Details
Address: 2 Headquarters Plaza, East Building Morristown, New Jersey 07960 United States | |
| Website | ir.whitehawktx.com |
Stock Details
| Ticker Symbol | WHWK |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001422142 |
| CUSIP Number | 00032Q104 |
| ISIN Number | US00032Q1040 |
Key Executives
| Name | Position |
|---|---|
| Dr. David J. Lennon Ph.D. | President, Chief Executive Officer and Director |
| Dr. Neil P. Desai Ph.D. | Founder and Director |
| Scott M. Giacobello CPA | Chief Financial Officer, Treasurer, Investor Relations and Corporate Communications |
| Bryan Ball | Chief Technical Operations Officer |
| Dr. David Dornan Ph.D. | Chief Scientific Officer |
| Stephen M. Rodin J.D. | Senior Vice President of Legal and General Counsel |